Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.[ Read More ]
The intrinsic value of one EMBC stock under the base case scenario is HIDDEN Compared to the current market price of 14.6 USD, Embecta Corp. is HIDDEN
Current Assets | 749 M |
Cash & Short-Term Investments | 326 M |
Receivables | 17.9 M |
Other Current Assets | 405 M |
Non-Current Assets | 465 M |
Long-Term Investments | 0 |
PP&E | 323 M |
Other Non-Current Assets | 142 M |
Current Liabilities | 354 M |
Accounts Payable | 53.5 M |
Short-Term Debt | 13.1 M |
Other Current Liabilities | 287 M |
Non-Current Liabilities | 1.68 B |
Long-Term Debt | 1.64 B |
Other Non-Current Liabilities | 41.8 M |
Revenue | 1.12 B |
Cost Of Revenue | 371 M |
Gross Profit | 750 M |
Operating Expenses | 528 M |
Operating Income | 222 M |
Other Expenses | 151 M |
Net Income | 70.4 M |
Net Income | 70.4 M |
Depreciation & Amortization | 32.6 M |
Capital Expenditures | -26.5 M |
Stock-Based Compensation | 21.5 M |
Change in Working Capital | -80 M |
Others | -57.2 M |
Free Cash Flow | 41.2 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
9 months ago
Feb 12, 2024
|
Bought 32.5 K USD
|
Melcher David F
Director |
+ 2000
|
16.25 USD |
1 year ago
Sep 08, 2023
|
Bought 98.3 K USD
|
Melcher David F
Director |
+ 6233
|
15.7662 USD |
1 year ago
Aug 10, 2023
|
Bought 109 K USD
|
Kurdikar Devdatt
President and CEO |
+ 5000
|
21.81 USD |
1 year ago
Aug 10, 2023
|
Bought 102 K USD
|
Mann Jeffrey Z
SVP, GC, Head Corp. Dev., Secy |
+ 4700
|
21.67 USD |
1 year ago
Aug 10, 2023
|
Bought 100 K USD
|
Elguicze Jacob
SVP and CFO |
+ 4625
|
21.6637 USD |
1 year ago
Feb 15, 2023
|
Bought 102 K USD
|
Melcher David F
Director |
+ 3100
|
32.925 USD |
1 year ago
Feb 15, 2023
|
Bought 101 K USD
|
Melcher David F
Director |
+ 3100
|
32.51 USD |